Quick Listen: Scrip’s Five Must-Know Things

 
• By Ian Haydock

In this week's podcast version of Five Must-Know Things, hear about whether safety concerns may affect JAK inhibitors, Takeda’s strategic R&D plans, Cigna’s psoriasis insurance program, Phase III readouts to look for, and an overview of the global pharma R&D pipeline.

Scrip Five Must Know Things
Weekly Audio Roundup Of Global Biopharma News

More from Business

More from Scrip